CASZ1 and neoplasm: In subtype embryonal rhabdomyosarcoma, the aberrantly upregulated MAP kinase kinase (MEK) suppresses CASZ1 expression and impairs the autoregulated pathway composed of CASZ1, MYOD, and MYOG, thus inhibiting tumor cells from differentiating into skeletal muscles [18].